The association of homocysteine and coronary artery disease

Gregory M Gauthier1, Jon G Keevil, Patrick E McBride

  • 1Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA. gm.gauthier@hosp.wisc.edu

Clinical Cardiology
|December 18, 2003
PubMed

Insights

High homocysteine levels (hyperhomocysteinemia) are linked to heart disease risk. Folic acid effectively lowers homocysteine, but its impact on preventing heart events requires further study.

Area of Science:

  • Cardiovascular Science
  • Biochemistry
  • Nutritional Science

Background:

  • Hyperhomocysteinemia is associated with increased risk of atherosclerosis and myocardial infarction.
  • Elevated homocysteine levels can result from genetic factors, nutritional deficiencies, diseases, or medications.

Purpose of the Study:

  • To review the biochemistry of homocysteine metabolism.
  • To discuss the etiology and pathogenesis of hyperhomocysteinemia.
  • To explore the association between hyperhomocysteinemia and coronary artery disease, including screening and treatment options.

Main Methods:

  • Literature review of prospective case-control studies.
  • Analysis of biochemical pathways and genetic factors.
  • Examination of clinical trial data on homocysteine-lowering therapies.

Main Results:

  • Hyperhomocysteinemia is a risk factor for cardiovascular events.
  • Folic acid and B-complex vitamins effectively reduce homocysteine concentrations.
  • The clinical benefit of homocysteine reduction on coronary event risk remains uncertain.

Conclusions:

  • Hyperhomocysteinemia is a significant risk factor for cardiovascular disease.
  • While effective in lowering homocysteine, the role of folic acid in preventing coronary events needs further investigation.
  • Comprehensive understanding of homocysteine metabolism and its clinical implications is crucial for cardiovascular health.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...